Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women

Clinical trial NCT05154578 · COMPLETED

Trial details

NCT number: NCT05154578
Sponsor: Minervax ApS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Group B Streptococcal Infection

Start date: 2022-02-17
Primary completion: 2023-04-26
Enrollment: 269

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.